Source: Annual Congress 2009 - Imaging of COPD, asthma and emphysema in evolution
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Del Puerto-Nevado, S. Perez-Rial, A. Kyriazis, J. J. Diaz-Gil, N. Gonzalez-Mangado, J. Ruiz-Cabello, G. Peces-Barba (Madrid, Spain). Liver growth factor ameliorates tobacco induced experimental emphysema. Non-invasive fluorescent molecular imaging approach. Eur Respir J 2009; 34: Suppl. 53, 2905

Member's Comments

No comment yet.

Related content which might interest you: Ozone induced acute and chronic alterations in the lung in mice: a combined digital imaging and functional analysis. Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels Year: 2018 Non-invasive molecular imaging of pulmonary fibrosis Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease Year: 2018 Molecular markers involved in susceptibility to lung injury after acute exposure to tobacco smoke in different mouse strains. Fluorescent molecular in vivo imaging application Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 Novel imaging biomarkers for assessment of lung fibrosis and inflammation Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease Year: 2021 Liver growth factor (LGF) reverts experimental lung emphysema induced by tobacco smoke in mice Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012 In vivo imaging of NF-kB pathway in acute lung inflammation mouse model can predict a pharmacological response Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 Influence of early growth on childhood lung function assessed by magnetic resolution imaging and spirometry. The Generation R Study. Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology Year: 2017 FDG-microPET imaging to comfirm brain death in a mouse model: A useful tool to study related donor lung injury Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 Morphometric study of hypoxia inducible factor-1α-vascular endothelial growth factor (HIF-1α-VEGF) axis in patients with idiopathic pulmonary fibrosis with the use of tissue microarrays Source: Eur Respir J 2006; 28: Suppl. 50, 338s Year: 2006 Molecular imaging of the progression of pulmonary fibrosis using animal models of disease Source: Eur Respir J 2006; 28: Suppl. 50, 605s Year: 2006 PBI-compound, a novel first-in-class anti-fibrotic compound, inhibits CTGF and collagen production in murine and human fibroblasts, and reduces lung fibrosis in the bleomycin-induced lung fibrosis model Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 In-vivo lung molecular imaging of choline metabolism in a rat model of pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 FGF-9 overexpression prevents pleural fibrosis induced by intra-pleural adenovirus injection in mice Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging Source: International Congress 2015 – New insights into IIPs Year: 2015 Clinical yield of vibration response imaging technology for pleural diseases Source: Annual Congress 2006 - New modalities and application in imaging of the chest Year: 2006 MRI and CT imaging of in vivo models of drug-induced interstitial lung diseases. Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease Year: 2018 Role of quantitative perfusion scintigraphy evaluation in determination of the efficiency of the procedure before lung volume reduction coil (LVRC) treatment for severe emphysema Source: International Congress 2016 – Airway stenting and ablation Year: 2016 LATE-BREAKING ABSTRACT: Molecular imaging with CXCR4-gallium-68-pentixafor PET correlates with GAP index and treatment effects in idiopathic pulmonary fibrosis Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016 Shear Wave imaging (SVI): A potential tool for analyzing early fibrotic changes in the subpleural space Source: Annual Congress 2013 –The different modalities for current imaging and for future issues Year: 2013 Assessing regional lung function in emphysema using a new, vibration response imaging (VRI*) technology Source: Eur Respir J 2005; 26: Suppl. 49, 315s Year: 2005